Amneal Pharmaceuticals Inc Class A (AMRX) Financials

$17.01

$4.83 (39.66%)

As on 11-Sep-2026 16:18EDT

Market cap

$5,925 Mln

Revenue (TTM)

$3,118 Mln

P/E Ratio

35.4

P/B Ratio

177.9

Div. Yield

0 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	3,117.55	3,018.76	2,793.96	2,393.61	2,212.30	2,093.67
Cost of Revenue	1,891.76	1,882.67	1,773.52	1,529.74	1,420.84	1,324.70
Gross Profit	1,225.79	1,136.09	1,020.44	863.87	791.46	768.97
Operating Expenses	822.55	713.00	771.11	659.50	886.39	616.26
Operating Profit (EBIT)	403.24	423.09	249.33	204.37	-94.93	152.72
Other Income	--	--	--	--	5.18	14.98
Profit before Tax	201.18	139.21	-55.01	-40.27	-248.13	31.37
Provision for Tax	-14.14	11.28	18.86	8.45	6.66	11.20
Profit after Tax (Net Income)	157.36	72.06	-116.89	-83.99	-129.99	10.62
Minority Interest	-57.96	-55.88	-43.01	-35.27	-125.24	9.55
Consolidated Profit	--	--	--	--	-129.99	10.62

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	33.02	-70.79	-109.27	19.78	298.42	360.34
Minority Interest	-57.96	--	--	--	-114.44	6.63
Non-Current Liabilities	2,776.18	2,790.68	2,416.21	2,564.67	2,837.61	2,895.45
Current Liabilities	883.19	881.63	1,129.77	846.60	752.80	677.24
Total Liabilities	4,659.54	3,678.28	3,501.45	3,472.57	3,799.34	3,939.66

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	1,829.32	1,767.10	1,913.64	2,094.71	2,387.52	2,419.56
Current Assets	1,947.03	1,911.18	1,587.81	1,377.86	1,411.82	1,520.11
Total Assets	4,659.54	3,678.28	3,501.45	3,472.57	3,799.34	3,939.66
Total Debt*	2,791.76	2,736.47	2,593.14	2,750.52	2,845.14	2,876.06
Net Current Assets	1,063.84	1,029.55	458.04	531.27	659.02	842.87

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	339.99	295.10	345.58	65.10	241.82
Cash Flow from Investing Activities	--	-112.26	-63.00	-69.19	-174.31	-194.18
Cash from Financing Activities	--	-31.53	-211.79	-212.57	-106.62	-138.12
Net Cash Inflow / Outflow	--	--	--	--	-215.83	-90.48

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	0.48	0.22	-0.38	-0.34	-0.86	0.07
Cash EPS ($)	0.48	0.91	0.39	0.60	0.73	1.63
Adjusted Book Value ($)	0.10	--	--	0.08	1.97	2.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.05	0.95	1.42	0.43	1.62
Free Cash Flow per Share ($)	--	0.83	0.71	1.13	-0.17	1.30

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	2.80	-4.45	-2.84	-4.07	0.32
ROE (%)	--	-80.04	261.24	-52.79	-39.46	3.20
ROA (%)	3.42	2.01	-3.35	-2.31	-3.36	0.27
EBIT Margin (%)	14.69	12.60	7.29	11.34	9.04	8.01
Net Margin (%)	5.05	2.39	-4.18	-3.51	-5.86	0.50
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	9.28	0.08	0.17	0.08	0.06	0.05
EBIT Growth (%)	35.27	86.80	-24.98	35.67	19.29	52.14
Net Profit Growth (%)	323.42	161.65	-39.16	35.38	-1,323.51	-88.33
EPS Growth (%)	7,441.17	1.59	-0.09	0.60	-13.06	-0.88
Book Value Growth (%)	128.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	35.44	56.80	-20.99	-17.61	-2.32	67.35
Price / Book Value	177.92	-57.81	-22.46	74.79	1.01	1.99
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13.71	10.79	11.22	8.26	7.08	8.33
Close Price ($)	17.31	12.60	7.92	6.07	1.99	4.79
High Price ($)	17.86	13.01	9.47	6.30	5.11	7.45
Low Price ($)	7.67	6.69	--	1.24	1.95	3.89
Market Cap ($ Cr)	5,924.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	77.65	-38.65	-23.73	139.05	9.53	7.98
Short term debt to equity ratio	3.68	-0.30	-3.11	11.51	0.35	0.13
Current Ratio	2.20	2.17	1.41	1.63	1.88	2.24
Quick Ratio	1.44	1.48	0.86	0.94	1.17	1.52
Interest Coverage	1.88	1.58	0.79	1.29	1.26	1.23

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	32.74	31.13	27.76	26.97	33.53	33.18
Asset Turnover	0.68	0.84	0.80	0.66	0.57	0.53
Receivable days	--	103.79	92.91	105.86	118.59	116.34
Inventory Days	--	118.22	122.93	132.77	131.12	135.11
Payable days	--	49.91	41.54	37.06	38.29	39.32
Cash Conversion Cycle	--	172.10	174.30	201.57	211.41	212.13

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)